“静脉血栓栓塞症”单中心真实世界临床诊疗实践分析研究  

A single-center real-world analysis of the clinical treatment of venous thromboembolism

作　　者：陈兵[1] 朱永斌[2] 何源 潘以锋[1] 王洪亚[1] 李苹 朱世钧 Bing Chen;Yongbin Zhu;Yuan He;Yifeng Pan;Hongya Wang;Ping Li;Shijun Zhu(Department of Vascular Surgery,The Second Affiliated Hospital of Zhejiang University School of Medicine,Hangzhou 310009,China;Medical Department,The Second Affiliated Hospital of Zhejiang University School of Medicine,Hangzhou 310009,China)

机构地区：[1]浙江大学医学院附属第二医院血管外科,杭州310009 [2]浙江大学医学院附属第二医院医务处,杭州310009

出　　处：《中华血管外科杂志》2023年第2期178-182,共5页Chinese Journal of Vascular Surgery

基　　金：国家自然科学基金(81270116);北京市自然科学基金(7132076);浙江省医学会临床科研基金项目(2021ZY-A70)。

摘　　要：静脉血栓栓塞症(VTE)是临床发病率较高的疾病和合并症, 是造成低风险死亡事件和医疗纠纷的重要因素。近年来, 在国家卫生健康委员会和有关部门推动下, 建立了积极的VTE风险评估、预防策略和指南, 取得了非常好的成绩。然而仍然缺乏大规模VTE发病率调查数据, 而不同层级医院、科室对于VTE的整体评估、预防、治疗差异较大。本文就单中心两年的官方数据进行收集整理, 对VTE的发病率和真实世界抗凝药物应用进行分析总结, 为本领域进一步发展提供基础数据。Venous thromboembolism(VTE)is a disease and complication with high clinical incidence,an important factor causing low-risk death events and medical disputes.In recent years,promoted by the National Health Commission and relevant departments,positive risk assessment and prevention strategies and guidelines for VTE have been established,and good results have been achieved.However,we still lack large-scale survey data on the incidence of venous thrombosis,and the overall assessment,prevention and treatment of VTE vary greatly among different levels of hospitals and departments.This paper collects the official data in our single center for two years,analyzes and summarizes the incidence of VTE and the application of anticoagulant drugs in the real world,and provides basic data for the further development of this field.

关 键 词：静脉血栓栓塞症 肺动脉栓塞 静脉血栓栓塞症风险评估 抗凝治疗 

分 类 号：R543.6[医药卫生—心血管疾病]